Paid Clinical Trials in The Woodlands, TX
As of June 2026, 131 paid clinical trials are recruiting in The Woodlands, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
The Woodlands offers studies at sites including Houston Methodist The Woodlands Hospital for conditions such as Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Age-Related Macular Degeneration, Geographic Atrophy. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in The Woodlands
Trials by drug in The Woodlands
Filter results
131 clinical trials
↓ Download CSVA Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
I-DECIDE After Bronchiolitis Hospitalization
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
About research studies in The Woodlands
The Woodlands has approximately 131 recruiting research studies across a wide range of therapeutic areas. Texas hosts major cancer and cardiovascular research centers including MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and the Texas Medical Center — the largest medical complex in the world.
Top Research Study Locations in The Woodlands
Researchers run research studies in The Woodlands, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Houston Methodist The Woodlands Hospital | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Stage IIIB Lung Cancer AJCC v8 | 19 |
| Retina Consultants of Texas | Geographic Atrophy, AMD, Age - Related Macular Degeneration (AMD) | 12 |
| Renovatio Clinical | Lymphoma, Non-Small Cell Lung Cancer, 1st Line NSCLC | 11 |
| Family Psychiatry of The Woodlands | Autism Spectrum Disorder, Depressive Disorder, Treatment-Resistant, Major Depressive Disorder (MDD) | 11 |
| Texas Oncology - Gulf Coast | Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma | 10 |
| Advanced Rheumatology of Houston | Sjögren's Syndrome, Systemic Lupus Erythematosus (SLE), Radiographic Axial Spondyloarthritis | 3 |
| Advanced Rheumatology of Houston - Woodlands | Osteoarthritis, Overweight or Obesity, Psoriatic Arthritis | 3 |
| Texas Oncology-The Woodlands | Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma | 3 |
| Texas Oncology - The Woodlands | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant | 3 |
| Houston Methodist The Woodlands | Rotator Cuff Injuries, Rotator Cuff Tears | 2 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| Renovatio Clinical 1 | Carcinoma, Non-Small-Cell Lung, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma | 2 |
| Renovatio Clinical-The Woodlands-69551 | Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis | 2 |
| Retina Consultants Texas | Geographic Atrophy (GA), Age-related Macular Degeneration (AMD) | 2 |
| Retina Consultants of Texas (Woodlands) | Macular Edema Secondary to Inflammation | 2 |
| Texas Oncology Gulf Coast | Immune Thrombocytopenia (ITP), Myelodysplastic Syndromes | 2 |
| Texas Oncology- Gulf Coast | Advanced Cancer, Metastatic Cancer, Platinum-resistant Ovarian Cancer | 2 |
| The Woodlands, TX | Branch Retinal Vein Occlusion (BRVO), Neovascular (Wet) Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration (NVAMD) | 2 |
| US Oncology Research Network | Neoplasm Metastasis, Breast Neoplasms, Carcinoma, Transitional Cell | 2 |
| US Oncology | Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms | 1 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Ability and Beyond | 22q11.2 Deletion Syndrome, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD | 1 |
| Advanced Rheumatology of Houston - The Woodlands | Psoriatic Arthritis | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Align Clinic | Scoliosis Idiopathic Adolescent Treatment | 1 |
Active & Upcoming Studies in The Woodlands (2026)
Recruiting trials in The Woodlands grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (57 active studies)
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
Eye & vision (21 active studies)
- Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration · Phase 1, Phase 2 · Eyconis INC.
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Mental health & behavior (5 active studies)
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
- Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder · Phase 2 · AbbVie
Neurology & pain (5 active studies)
- The Fourth Left Atrial Appendage Occlusion Study · Hamilton Health Sciences Corporation
- Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine · Phase 3 · AbbVie
Diabetes & metabolic (2 active studies)
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) · Phase 4 · Eli Lilly and Company
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease · Phase 3 · Prokidney
Cardiovascular (2 active studies)
- The Fourth Left Atrial Appendage Occlusion Study · Hamilton Health Sciences Corporation
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products · Medtronic
Pediatric (1 active study)
- Rethinking Rigidity: Development of a 3D-Printed Scoliosis Brace With Varying Flexibility · Baylor College of Medicine
Common conditions studied in The Woodlands
- Non-Small Cell Lung Cancer (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Carcinoma, Non-Small-Cell Lung (4 active studies). Recruiting Carcinoma, Non-Small-Cell Lung studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Age-Related Macular Degeneration (3 active studies). Recruiting Age-Related Macular Degeneration studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Geographic Atrophy (3 active studies). Recruiting Geographic Atrophy studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Geographic Atrophy (GA) (3 active studies). Recruiting Geographic Atrophy (GA) studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Idiopathic Pulmonary Fibrosis (3 active studies). Recruiting Idiopathic Pulmonary Fibrosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in The Woodlands
- AbbVie
- Eli Lilly and Company
- Pfizer
- Hoffmann-La Roche
- National Cancer Institute (NCI)
Local regulations and guidelines
Clinical trials in Texas are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials run in Texas must also comply with the Texas Medical Privacy Act (TMPA), which extends federal HIPAA protections to a broader range of entities handling participant data.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in The Woodlands. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in The Woodlands
Hipa.ai aggregates every recruiting study in The Woodlands from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in The Woodlands?
There are approximately 131 recruiting clinical trials in The Woodlands, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in The Woodlands pay participants?
Most recruiting trials in The Woodlands compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in The Woodlands?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in The Woodlands?
The most common conditions under active study in The Woodlands include Non-Small Cell Lung Cancer (5), Carcinoma, Non-Small-Cell Lung (4), Age-Related Macular Degeneration (3), Geographic Atrophy (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in The Woodlands?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in The Woodlands on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in The Woodlands?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in The Woodlands?
Recruiting research sites in The Woodlands include Houston Methodist The Woodlands Hospital, Retina Consultants of Texas, Renovatio Clinical, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in The Woodlands right now?
The largest active categories in The Woodlands are Cancer & tumors (57), Eye & vision (21), Mental health & behavior (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.